Patients with ground-glass lesions are a seemingly biochemically specific subgroup of intrathoracic sarcoidosis, with increased levels of SAA, CXCL9, CXCL10, CCL18, CTO, and CA15.3. This evidence concerns the gene CCL18 and sarcoidosis.